In April 2026, Canada became the first G7 country to approve a generic version of semaglutide
With the ongoing development of novel chemical modifications and targeted delivery systems, more siRNA drugs are anticipated to enter the market soon
DIM This powerful, optimizing natural component balances the metabolism of estrogen in the body
5 Obesity is the main risk factor for obstructive sleep apnea, raising the possibility that weight loss may reduce incidence of this disorder, along with the need for continuous positive airway pressure (CPAP) devices
The Once-Weekly Revolution in Insulin For 100 years, insulin has been a daily burden
By optimizing the bodys response to insulin, glutathione contributes to better glucose regulation, potentially reducing the risk of insulin resistance and associated complications